Abstract:Background: Controlled drug delivery system is highly important for not only prolonged the efficacy of drug but also cellular development for tissue engineering. A number of biopolymer composites and nanostructured carriers behave been used for the controlled drug delivery of therapeutics. Recently, in vitro microfluidic devices that mimic the human body have been developed for drug-delivery applications. Methods: A microfluidic channel was fabricated via a two-step process: (i) polydimethyl siloxane (PDMS) and curing agent were poured with a 10:2 mass ratio onto an acrylic mold with two steel pipes, and (ii) calcium alginate beads were synthesized using sodium alginate and calcium chloride solutions. Different amounts (10, 25, 50 μg) of graphene oxide (GO) were then added by Hummers method, and studies on the encapsulation and release of the model drug, risedronate (Ris), were performed using control hydrogel beads (pH 6.3), GO-containing beads (10GO, 25GO and 50GO), and different pH conditions. MC3T3 osteoblastic cells were cultured in a microchannel with Ris-loaded GO-hydrogel beads, and their proliferation, viability, attachment and spreading were assessed for a week. Results: The spongy and textured morphology of pristine hydrogel beads was converted to flowery and rod-shaped structures in drug-loaded hydrogel beads at reduced pH (6.3) and at a lower concentration (10 μg) of GO. These latter 10GO drug-loaded beads rapidly released their cargo owing to the calcium phosphate deposited on the surface. Notably, beads containing a higher amount of GO (50GO) exhibited an extended drug-release profile. We further found that MC3T3 cells proliferated continuously in vitro in the microfluidic channel containing the GO-hydrogel system. MTT and live/dead assays showed similar proliferative potential of MC3T3 cells. Therefore, a microfluidic device with microchannels containing hydrogel beads formulated with different amounts of GO and tested under various pH conditions could be a promising system for controlled drug release. Conclusions: The GO and drug (risedronate, Rig) were directed loaded into a hydrogel placed in a microchannel. Through interactions such as hydrogen bonding between Go and the Rig-loaded GO-hydrogel beads, the bead-loaded microfluidic device supported MC3T3 proliferation and development as osteoblast without additional osteogenic differentiation supplements.

Preparation and Characterization of Polymeric Microbeads Incorporated with Reduced Graphene Oxide for Drug Delivery and Antibacterial Applications

Preparation and Characterization of Sodium Alginate-reduced Graphene Oxide Microbeads for Co-Delivery of Doxorubicin and 5-Fluorouracil

Development of pH‐Sensitive Microbeads Incorporated with Amine‐Functionalized Magnetic Nanoparticles for Enhanced Antibacterial Activity

Natural Polymer-Based Graphene Oxide Bio-nanocomposite Hydrogel Beads: Superstructures with Advanced Potentials for Drug Delivery

Preparation and in vitro characterization of graphene oxide impregnated superporous hydrogel beads: an effective approach of gastro-retentive drug delivery system

Fabrication of a microfluidic device for studying the in situ drug-loading/release behavior of graphene oxide-encapsulated hydrogel beads

Hydrolyzed polyacrylamide grafted maize starch based microbeads: Application in pH responsive drug delivery

ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy

Polyethylene Glycol Functionalized Graphene Oxide Nanoparticles Loaded with Nigella sativa Extract: A Smart Antibacterial Therapeutic Drug Delivery System

The effect of PEGylation components on drug release behavior of targeted reduced graphene oxide based drug delivery system

Development and Evaluation of pH‐Responsive Microbeads Incorporated with Nickel Zinc Ferrite Nanoparticles for Controlled Release of Doxorubicin

Alginate Microbeads Containing Halloysite and Layered Double Hydroxide as Efficient Carriers of Natural Antimicrobials

Polymer Grafting of Graphene Oxide Through Esterification of Terephthalic Acid and Allyl Alcohol for Metronidazole Drug Delivery: Central Composite Design Optimization Study

Fabrication of pH-Responsive Chitosan/Polyvinylpyrrolidone Hydrogels for Controlled Release of Metronidazole and Antibacterial Properties

The construction and characterization of pH-sensitive agar/alginate hydrogel beads for targeted drug delivery to the intestine

Chitosan/Poly Vinyl Alcohol/Graphene Oxide Based pH-Responsive Composite Hydrogel Films: Drug Release, Anti-Microbial and Cell Viability Studies

Photodynamic Graphene Oxide Combined Alginate Hydrogel for Controlled Drug Release

Preparation and Evaluation of pH-Sensitive Chitosan/Alginate Nanohybrid Mucoadhesive Hydrogel Beads: An Effective Approach to a Gastro-Retentive Drug Delivery System

Hydrogel beads based on carboxymethyl cassava starch/alginate enriched with MgFe2O4 nanoparticles for controlling drug release

Preparation of self-healable nanocomposite hydrogel based on Gum Arabic/gelatin and graphene oxide: study of drug delivery behavior

Sustained Ampicillin Loading and Releasing Ability of Novel In-Situ Ca2+ Functionalized Ternary GO/PVP/CMC Nanocomposite Hydrogel